The Allen Institute, the Chan Zuckerberg Initiative and the University of Washington have launched a collaboration called the Seattle Hub for Synthetic Biology, with the goal of using genetically modified… Read More
A Seattle startup that took root at the University of Washington has closed a $2.8 million seed round for a drug discovery platform that can sort through millions of protein… Read More
Alexandre Zanghellini can’t help but think about what makes up the world around him. Sitting in a conference room, Zanghellini considered the paint on the walls, the table, the window… Read More
A-Alpha Bio, a startup aiming to speed up the development of new drugs, announced Tuesday it has won a $225,000 grant from the National Science Foundation (NSF). The funding brings… Read More
Vancouver, Wash.,-based biotechnology company AbSci has raised a chunk of new money. The company announced Wednesday that it has just completed an oversubscribed $12 million Series C round of funding.… Read More
Researchers have reached a new milestone in their effort to expand the genetic alphabet of life by designing a strain of E. coli bacteria that creates proteins unlike anything cells… Read More
Arzeda does work that sounds out of this world — or maybe straight out of science fiction. The company uses fermentation, the same process that gives us beer, to invent completely… Read More
Proteins are incredibly important, but incredibly complicated, molecules. They control 98 percent of all biological functions and are used in industries from manufacturing to agriculture. Seattle-based synthetic biology startup Arzeda has… Read More
Researchers from the University of Washington have taken advantage of synthetic biology to turn yeast cells into building blocks for digital information processing. The experiment, described today in Nature Communications, turned… Read More